Literature DB >> 12117953

ADP and other metabolites released from Acanthamoeba castellanii lead to human monocytic cell death through apoptosis and stimulate the secretion of proinflammatory cytokines.

A Mattana1, V Cappai, L Alberti, C Serra, P L Fiori, P Cappuccinelli.   

Abstract

Monocytes/macrophages are thought to be involved in Acanthamoeba infections. The aim of this work was to study whether soluble metabolites (ADP and other compounds) released by Acanthamoeba castellanii trophozoites could induce morphological and biochemical changes in human monocytic cells in vitro. We demonstrate here that ADP constitutively released in the medium by A. castellanii, interacting with specific P2y(2) purinoceptors expressed on the monocytic cell membrane, caused a biphasic rise in [Ca(2+)](i), morphological changes characteristics of cells undergoing apoptosis, caspase-3 activation, and secretion of tumor necrosis factor alpha (TNF-alpha). The same results were found in monocytes exposed to purified ADP. Cell damage and TNF-alpha release induced by amoebic ADP were blocked by the P2y(2) inhibitor suramin. Other metabolites contained in amoebic cell-free supernatants, with molecular masses of, respectively, >30 kDa and between 30 and 10 kDa, also caused morphological modifications and activation of intracellular caspase-3, characteristics of programmed cell death. Nevertheless, mechanisms by which these molecules trigger cell damage appeared to differ from that of ADP. In addition, other amoebic thermolable metabolites with molecular masses of <10 kDa caused the secretion of interleukin-1beta. These findings suggest that pathogenic free-living A. castellanii by release of ADP and other metabolites lead to human monocytic cell death through apoptosis and stimulate the secretion of proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117953      PMCID: PMC128125          DOI: 10.1128/IAI.70.8.4424-4432.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Purification of human monocytes/macrophages by adherence to cytodex microcarriers.

Authors:  L M Kumaratilake; A Ferrante
Journal:  J Immunol Methods       Date:  1988-09-13       Impact factor: 2.303

2.  Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases.

Authors:  S Berchtold; A L Ogilvie; C Bogdan; P Mühl-Zürbes; A Ogilvie; G Schuler; A Steinkasserer
Journal:  FEBS Lett       Date:  1999-09-24       Impact factor: 4.124

3.  In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii.

Authors:  Y G He; J Y Niederkorn; J P McCulley; G L Stewart; D R Meyer; R Silvany; J Dougherty
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-11       Impact factor: 4.799

Review 4.  Immunity to Acanthamoeba.

Authors:  A Ferrante
Journal:  Rev Infect Dis       Date:  1991 Mar-Apr

5.  P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide.

Authors:  M Warny; S Aboudola; S C Robson; J Sévigny; D Communi; S P Soltoff; C P Kelly
Journal:  J Biol Chem       Date:  2001-05-10       Impact factor: 5.157

6.  The human monocyte-like cell line THP-1 expresses Fc gamma RI and Fc gamma RII.

Authors:  H B Fleit; C D Kobasiuk
Journal:  J Leukoc Biol       Date:  1991-06       Impact factor: 4.962

7.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

8.  Conditioned medium from stimulated mononuclear leukocytes augments human neutrophil-mediated killing of a virulent Acanthamoeba sp.

Authors:  A Ferrante; T J Abell
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

9.  IFN-gamma and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells.

Authors:  E Vey; J H Zhang; J M Dayer
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

10.  Effects of muramyl dipeptide and trehalose dimycolate on resistance of mice to Toxoplasma gondii and Acanthamoeba culbertsoni infections.

Authors:  K N Masihi; C R Bhaduri; H Werner; K Janitschke; W Lange
Journal:  Int Arch Allergy Appl Immunol       Date:  1986
View more
  15 in total

1.  Acanthamoeba Activates Macrophages Predominantly through Toll-Like Receptor 4- and MyD88-Dependent Mechanisms To Induce Interleukin-12 (IL-12) and IL-6.

Authors:  Antonella Cano; Antonella Mattana; Stuart Woods; Fiona L Henriquez; James Alexander; Craig W Roberts
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

2.  Extracellular protease profile of Acanthamoeba after prolonged axenic culture and after interaction with MDCK cells.

Authors:  Cecília Cirelli; Elaine Isabela Soares Mesquita; Isabela Aurora Rodrigues Chagas; Cinthia Furst; Cynara Oliveira Possamai; Jonatas Santos Abrahão; Ludmila Karen Dos Santos Silva; Marina Felipe Grossi; Carlos Alberto Tagliati; Adriana Oliveira Costa
Journal:  Parasitol Res       Date:  2019-12-17       Impact factor: 2.289

3.  P2Y12 receptor modulation of ADP-evoked intracellular Ca2+ signalling in THP-1 human monocytic cells.

Authors:  J J Micklewright; J A Layhadi; S J Fountain
Journal:  Br J Pharmacol       Date:  2018-04-29       Impact factor: 8.739

4.  Acanthamoeba castellanii induces host cell death via a phosphatidylinositol 3-kinase-dependent mechanism.

Authors:  James Sissons; Kwang Sik Kim; Monique Stins; Samantha Jayasekera; Selwa Alsam; Naveed Ahmed Khan
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Role of protease-activated receptors 2 (PAR2) in ocular infections and inflammation.

Authors:  Trivendra Tripathi; Hassan Alizadeh
Journal:  Receptors Clin Investig       Date:  2014

6.  Acanthamoeba castellanii promotion of in vitro survival and transmission of coxsackie b3 viruses.

Authors:  A Mattana; C Serra; E Mariotti; G Delogu; P L Fiori; P Cappuccinelli
Journal:  Eukaryot Cell       Date:  2006-04

7.  Characterisation and differentiation of pathogenic and non-pathogenic Acanthamoeba strains by their protein and antigen profiles.

Authors:  J Walochnik; K Sommer; A Obwaller; E-M Haller-Schober; H Aspöck
Journal:  Parasitol Res       Date:  2004-01-13       Impact factor: 2.289

8.  In vitro activity of Acanthamoeba castellanii on human platelets and erythrocytes.

Authors:  A Mattana; L Alberti; G Delogu; P L Fiori; P Cappuccinelli
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

Review 9.  Biology and pathogenesis of Acanthamoeba.

Authors:  Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Parasit Vectors       Date:  2012-01-10       Impact factor: 3.876

Review 10.  An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment.

Authors:  Jacob Lorenzo-Morales; Naveed A Khan; Julia Walochnik
Journal:  Parasite       Date:  2015-02-18       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.